Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacogenetics for Antidepressant Dosing in Elderly Depression
NCT02856477Terminated
- Sponsor
- CHU de Besançon
- Start
- Nov 2007
- Primary completion
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of antidepressant (TDDS/ODF) in major depressive disorder (MDD), sponsored by CHU de Besançon. Primary endpoint: Patient Remission at 6 months. Started Nov 2007; status: terminated.
02
Drugs
antidepressant (TDDS/ODF)
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT02856477.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02856477.